Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Study Investigating the Combination of Irinotecan, Vincristine and Anlotinib for Epithelioid Sarcoma

NCT05656222 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT05656222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05656222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Study Investigating the Combination of Irinotecan, Vincristine and Anlotinib for Epithelioid Sarcoma
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Withdrawn
Start date
August 1, 2021
Completion date
December 1, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

objective response, overall survival